Blue Earth Diagnostics

Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patients

Oxford, United KingdomFounded 2013blueearthdiagnostics.comWebsite technologies

+ Add to sales board

Highlights

  • Hiring30 open roles
  • New on EvolcAdded 2026-10-28
  • Salary transparent15 of 30 open roles list a salary

About Blue Earth Diagnostics

Blue Earth Diagnostics develops and commercialises PET radiopharmaceutical imaging agents. Its products include Axumin (fluciclovine F 18) for oncology, POSLUMA (flotufolastat F 18) and Cardiogen-82 (rubidium) for cardiology, which is commercialised in collaboration with Bracco. Product availability varies by country, subject to local regulatory approval.

The company's customers are clinicians and patients who use its imaging agents. Its products are marketed in markets where it or its partners hold marketing authorisations, including the US, UK and Europe, with some approvals held by partners in other countries such as South Korea and Taiwan.

Blue Earth Diagnostics was formed in 2013 in Oxford, UK, and has its headquarters at the Oxford Science Park. It has been a subsidiary of Bracco Imaging S.p.A. since its acquisition in 2019. A US headquarters office was opened in Needham, Massachusetts, in April 2025. The company's careers page lists openings in pharmaceutical development, nuclear medicine, manufacturing management, sales and marketing, and business operations.

Product: PET radiopharmaceutical imaging agents: Axumin (fluciclovine F 18), POSLUMA (flotufolastat F 18) and Cardiogen-82 (rubidium).

Jobs at Blue Earth Diagnostics (30)

Blue Earth Diagnostics is hiring for 30 roles, mostly in manufacturing, based in Singen and Milan.

See all 30 jobs at Blue Earth Diagnostics →

Companies hiring like Blue Earth Diagnostics

Leadership

  • Jonathan Allis · Founder
  • Marco Campione · President and Chief Executive Officer at Blue Earth Diagnostics

More biotech & pharma companies

  • Blue Earth Therapeutics

    Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapies
    Oxford, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Bounce Biomedical

    Develops regenerative implants for patients with cartilage and bone injuries in joints
    Abingdon, United KingdomBiotech & pharmaFounded 2008
    New on Evolc
  • Bridge Farm Bioscience

    Develops and manufactures plant-derived ingredients and extracts for pharmaceutical, nutraceutical and personal care businesses
    Lincolnshire, United KingdomBiotech & pharmaFounded 2001
    New on Evolc
  • C4X Discovery Holdings

    Discovers small molecule drugs for immuno-inflammatory diseases, with partnered programmes at Sanofi and AstraZeneca
    Leeds, United KingdomBiotech & pharmaFounded 2014
    New on Evolc
  • Camurus

    Develops long-acting medicines for patients with severe and chronic diseases
    Duxford, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Carus Animal Health

    Animal health company developing point-of-care diagnostics and antibiotic alternatives for vets, farms and aquaculture
    Stevenage, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Google Analytics 4
  • Google Universal Analytics
  • HubSpot
  • HubSpot CMS
  • jQuery